Highlights West Pharmaceutical Services, Inc.

Stocks

WST

US9553061055

Medical Equipment, Supplies & Distribution

Market Closed - NYSE Other stock markets 01:30:03 14/07/2026 am IST			5-day change	1st Jan Change
359.70 ^USD	+1.69%		+0.58%	+30.73%

13/07	BNP Paribas Initiates West Pharmaceutical Services at Outperform With $447 Price Target	MT
13/07	BNP Paribas Initiates West Pharmaceutical Services at Outperform With $447 Price Target	MT

Highlights

02/07	West Pharmaceutical Services Completes Sale of SmartDose 3.5mL Manufacturing Rights	MT
16/05	West Pharmaceutical says making progress in restoring global operations after cyberattack	RE
24/04	Tranche Update on West Pharmaceutical Services, Inc.'s Equity Buyback Plan announced on February 17, 2026.	CI
23/04	Top Midday Gainers	MT
23/04	West Pharmaceutical Services, Inc. Raises Earnings Guidance for the Full Year 2026	CI
23/04	West Pharmaceutical Services, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
23/04	West Pharmaceutical Services, Inc. Provides Earnings Guidance for the Second Quarter 2026	CI
23/04	West Pharmaceutical Q1 Non-GAAP Earnings, Net Sales Rise; Issues Q2 Guidance -- Shares Rise Pre-Bell	MT
23/04	(WST) West Pharmaceutical Services Expects Full Year 2026 Adjusted EPS Range $8.40 - $8.75, vs. FactSet Est of $8.01	MT
23/04	(WST) West Pharmaceutical Expects 2026 Revenue Range $3.3B - $3.35B, vs. FactSet Est of $3.25B	MT
23/04	(WST) West Pharmaceutical Services, Inc. Expects Q2 Revenue Range $830.0M - $850.0M	MT
23/04	(WST) West Pharmaceutical Services, Inc. Expects Q2 Adjusted EPS Range $2.05 - $2.12	MT
23/04	Earnings Flash (WST) West Pharmaceutical Services, Inc. Reports Q1 Revenue $844.9M, vs. FactSet Est of $780.3M	MT
23/04	Earnings Flash (WST) West Pharmaceutical Services, Inc. Posts Q1 Adjusted EPS $2.13 per Share, vs. FactSet Est of $1.68	MT
31/03	West Pharmaceutical Services, Inc. Expands Dublin Facility to Support High-Volume Injectable Therapies	CI
11/03	West Pharmaceutical Services, Inc. Reaffirms Previously Issued Guidance	CI
10/03	West Pharmaceutical President, CEO and Chair Eric Green Plans Retirement; Company Reaffirms Guidance	MT
18/02	West Pharmaceutical Services Maintains Quarterly Dividend, Authorizes $1 Billion Share Repurchase	MT
18/02	West Pharmaceutical Services, Inc. Declares Regular Quarterly Dividend on Common Stock, Payable on May 6, 2026	CI
18/02	West Pharmaceutical Authorizes $1 Billion Share Repurchase Program	RE
18/02	West Pharmaceutical Services, Inc. announces an Equity Buyback for $1,000 million worth of its shares.	CI
17/02	West Pharmaceutical Services, Inc. authorizes a Buyback Plan.	CI
12/02	West Pharma forecasts 2026 profit above estimates on strong demand for drug components	RE
12/02	West Pharma forecasts 2026 profit above estimates on strong demand for drug components	RE
12/02	West Pharmaceutical Services, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2025	CI